Company: APXIF
Filing Date: 2025-07-18
Form Type: F-4/A
Source: 0001213900-25-065703
Chunk: 125

Company: APx Acquisition Corp. I
Filing Date: 2025-07-18
Form: F-4/A
Chunk 125
---
IBIC is valid for 30 years from the signing date and will be automatically renewed for ten -yearperiods unless terminated with proper notice. We must also maintain satisfactory arrangements for the manufacture and distribution of our tests and operate certified lab facilities to process our tests and provide patient results. Failure to augment our operational resources organically or through collaborations with third parties may have an adverse impact on our business, financial condition, results of operations and growth prospects. Potential changes in our leadership could adversely affect our business. Our success depends in large part on the skill, experience, and performance of our executive management team and others in key leadership positions. The continued efforts of these persons will be critical to us as we continue to develop our technologies and focus on growing our business. If we lose one or more of these key executives, we could experience difficulties maintaining our operations, including our ability to compete effectively, advance our technologies, develop new tests and implement our business strategies. Such changes in our executive management, and any future changes, as well as the effects of our business realignment, could also disrupt our business, and could impact our ability to preserve our culture, which could negatively affect our ability to recruit and retain personnel. Further, these changes may also increase our dependency on other members of our executive team. If we lose the services of any member of the executive management team or any key personnel, we may not be able to secure a suitable or qualified replacement, which could disrupt our business and could be particularly disruptive considering our strategic realignment in connection with the Business Combination. We rely on highly skilled personnel in a broad array of disciplines and, if we are unable to attract and retain additional qualified personnel, we may not be able to maintain the quality of our tests and services or grow effectively. Our business, including our research and development programs and laboratory operations, largely depend on our continued ability to identify, hire, train, motivate and retain highly skilled personnel for all areas of our organization, including software developers, geneticists, biostatisticians, certified laboratory directors, and other scientific and technical personnel to process and interpret our genetic tests. In addition, we may need to continue to expand our sales force with qualified and experienced personnel. All of our employees outside of Argentina are at will, which means that either we or the employee may terminate their employment at any time. Most of our employees are located in Argentina, and the dismissal of these employees would require severance payments in accordance with Argentine employment law. Competition in our industry for qualified employees is intense, and we may